ARCHIVES

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Accepts “Substantial” Settlement In New Copyright Claim

August 5, 1988

Program Announcement In Preventative Oncology

May 21, 1982

The Cancer Letter Marks 25th Anniversary

December 18, 1998

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007